Drug Shortage Report for DANTRIUM INTRAVENOUS

Last updated on 2018-07-31 History
Report ID 43728
Drug Identification Number 01997572
Brand name DANTRIUM INTRAVENOUS
Common or Proper name Dantrolene Sodium for Injection
Company Name ENDO PAR INNOVATION COMPANY, LLC
Active Ingredient(s) DANTROLENE SODIUM
Strength(s) 20MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size Box containing 6x20mg Vial
ATC code M03CA
ATC description MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-03-22
Estimated end date 2018-07-15
Actual end date 2018-07-30
Shortage status Resolved
Updated date 2018-07-31
Company comments
Health Canada comments
Contact Address 6 RAM RIDGE ROAD
CHESTNUT RIDGE, NEW YORK
UNITED STATES 10977
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-07-31 English Compare
v9 2018-07-30 French Compare
v8 2018-07-30 English Compare
v7 2018-05-16 French Compare
v6 2018-05-16 English Compare
v5 2018-05-01 French Compare
v4 2018-05-01 English Compare
v3 2018-03-23 English Compare
v2 2018-03-22 French Compare
v1 2018-03-22 English Compare